Moderna, Inc. (MRNA) FY2025 Annual Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2025-12-31

Swipe to see the full flow
Moderna, Inc. (MRNA) FY2025 Annual Balance SheetBalance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.Current liabilities$1.99 BLiabilities$3.69 BCurrent assets$6.54 BAssets$12.34 BNon-current liabilities$1.70 BEquity$8.65 BNon-current assets$5.79 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInvestmentsCash and cash equivalentsPrepaid expenses and other current assetsAccounts receivable, netInventoryInvestments, non-currentProperty, plant and equipment, netRight-of-use assets, operating leasesOther non-current assetsAccrued liabilitiesAccounts payableOther current liabilitiesDeferred revenueOperating lease liabilities, non-currentLong-term debtOther non-current liabilitiesDeferred revenue, non-currentFinancing lease liabilities, non-currentRetained earningsAdditional paid-in capitalAccumulated other comprehensive income (loss)Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityAccrued liabilitiesAccrued liabilities$1.39 BCurrent liabilitiesCurrent liabilities$1.99 BAccounts payableAccounts payable$317.00 MOther current liabilitiesOther current liabilities$185.00 MLiabilitiesLiabilities$3.69 BCurrent assetsCurrent assets$6.54 BInvestmentsInvestments$3.20 BDeferred revenueDeferred revenue$99.00 MAssetsAssets$12.34 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$653.00 MCash and cash equivalentsCash and cash equivalents$2.60 BNon-current liabilitiesNon-current liabilities$1.70 BLong-term debtLong-term debt$590.00 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$408.00 MOther non-current liabilitiesOther non-current liabilities$285.00 MAccounts receivable, netAccounts receivable, net$184.00 MDeferred revenue, non-currentDeferred revenue, non-current$153.00 MInventoryInventory$153.00 MFinancing lease liabilities, non-currentFinancing lease liabilities, non-current$20.00 MEquityEquity$8.65 BNon-current assetsNon-current assets$5.79 BInvestments, non-currentInvestments, non-current$2.34 BProperty, plant and equipment, netProperty, plant and equipment, net$2.13 BRetained earningsRetained earnings$7.22 BRight-of-use assets, operating leasesRight-of-use assets, operating leases$719.00 MOther non-current assetsOther non-current assets$605.00 MAdditional paid-in capitalAdditional paid-in capital$1.38 BAccumulated other comprehensive income (loss)Accumulated other comprehensive income (loss)$45.00 M
Chart details

Moderna, Inc. (MRNA) FY2025 Annual Balance Sheet

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

Assets
12,338,000,000 US dollars
Current assets
6,544,000,000 US dollars
Non-current assets
5,794,000,000 US dollars
Liabilities
3,688,000,000 US dollars
Current liabilities
1,987,000,000 US dollars
Non-current liabilities
1,701,000,000 US dollars
Equity
8,650,000,000 US dollars
Investments
3,204,000,000 US dollars
Cash and cash equivalents
2,595,000,000 US dollars
Prepaid expenses and other current assets
408,000,000 US dollars
Accounts receivable, net
184,000,000 US dollars
Inventory
153,000,000 US dollars
Investments, non-current
2,336,000,000 US dollars
Property, plant and equipment, net
2,134,000,000 US dollars
Right-of-use assets, operating leases
719,000,000 US dollars
Other non-current assets
605,000,000 US dollars
Accrued liabilities
1,386,000,000 US dollars
Accounts payable
317,000,000 US dollars
Other current liabilities
185,000,000 US dollars
Deferred revenue
99,000,000 US dollars
Operating lease liabilities, non-current
653,000,000 US dollars
Long-term debt
590,000,000 US dollars
Other non-current liabilities
285,000,000 US dollars
Deferred revenue, non-current
153,000,000 US dollars
Financing lease liabilities, non-current
20,000,000 US dollars
Retained earnings
7,223,000,000 US dollars
Additional paid-in capital
1,382,000,000 US dollars
Accumulated other comprehensive income (loss)
45,000,000 US dollars
Preferred stock, $0.0001; 162 shares authorized as of December 31, 2025 and 2024; no shares issued or outstanding at December 31, 2025 and 2024
0 US dollars
Common stock, par value $0.0001; 1,600 shares authorized as of December 31, 2025 and 2024; 394 and 386 shares issued and outstanding as of December 31, 2025 and 2024, respectively
0 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Moderna, Inc. (MRNA) FY2025 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!